Neuroprotective Effect of Butylphthalide for Cardiac Arrest Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 350 participants.
Also called NCT06572085
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 350 participants
- Sponsor
- Tang Ziren
- Registry
-
NCT06572085
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06572085. Randomized; quadruple masking; primary purpose treatment. Start 2022-01-01 (actual); primary completion 2027-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Neuroprotective Effect of Butylphthalide for Cardiac Arrest Patients
- Condition
- Butylphthalide
- Condition
- Cardiac Arrest
- Condition
- Neuroprotective Drugs
- Intervention (Drug)
- Butylphthalide and Sodium Chloride Injection
- Intervention (Drug)
- Saline Solution
- Lead sponsor
- Tang Ziren
Record details
- Record id
cardio:ct-nct06572085- Content hash
da292a21085dcdc621b65bfe45bcb9431707ddec63ccab8506827cf94cc64a2a